Beta Drugs Limited IPO
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. The company has a portfolio of over 50 products which is used for the treatment of various cancer diseases.
Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company’s manufacturing unit is located at Solan, Himachal Pradesh.
Company Strengths:
1. Focus on oncology segment. Manufacture over 50 products in this segment.
2. 18 product registrations in various countries. The company is in process of making additional 12 applications for product registration in various countries.
Objects of the Beta Drugs Limited IPO:
Beta Drugs Limited IPO Details:
| Open Date: | Sep 29 2017 |
| Close Date: | Oct 04 2017 |
| Total Shares: | 2,296,000 |
| Face Value: | ₹ 10 Per Equity Share |
| Issue Type: | Fixed Price Issue IPO |
| Issue Size: | 19.52 Cr. |
| Lot Size: | 1600 Shares |
| Issue Price: | ₹ 85 Per Equity Share |
| Listing At: | NSE Emerge |
| Listing Date: | Oct 12 2017 |
Promoters And Management:
Lead Manager of Beta Drugs Limited IPO:
Registrar of Beta Drugs Limited IPO:
Company Address:
Discussion on Beta Drugs Limited IPO:
Leave a Reply
You must be logged in to post a comment.